| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.52 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.25 | 3e-14 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-12 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |